Stock Movers: Eli Lilly, EchoStar, and UnitedHealth Group Discussed

EchoStar Spectrum Deal

• 🚀 EchoStar (SATS) shares surged approximately 70% to a record high after agreeing to sell spectrum licenses to AT&T for $23 billion.
• 💡 This deal is crucial for the company to stave off bankruptcy and address regulatory concerns regarding its airwave usage.
• 💰 The transaction, expected to close by mid-2026, also saw interest from Elon Musk's Starlink and T-Mobile for acquiring some of EchoStar's spectrum.
• 📈 EchoStar's bonds also saw significant gains in the junk bond market.

Eli Lilly's Obesity Pill Trial

• 💊 Eli Lilly (LLY), a nearly $700 billion company, saw its stock rally over 5.8% following positive trial results for its experimental obesity pill.
• 🎯 The pill helped patients lose 9.6% of their body weight in a recent trial, a more promising outcome than a previous trial earlier this month.
• 🏆 This development is significant in the competitive race for effective oral weight loss medications.

UnitedHealth Group Investigation

• 🔍 UnitedHealth Group (UNH) shares experienced a slight dip of 1.5% amid news of a Justice Department criminal division probe.
• ⚖️ The investigation is reportedly focusing on the company's prescription management services and how it reimburses its doctors.
• 📉 This probe adds to existing concerns for the largest U.S. health insurer, which has seen its stock down nearly 50% in the past 12 months despite recent investor interest.